Saturna Capital Corp Bristol Myers Squibb CO Transaction History
Saturna Capital Corp
- $7.45 Billion
- Q2 2024
A detailed history of Saturna Capital Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Saturna Capital Corp holds 501,533 shares of BMY stock, worth $27.2 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
501,533
Previous 677,079
25.93%
Holding current value
$27.2 Million
Previous $36.7 Million
43.27%
% of portfolio
0.28%
Previous 0.51%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,403Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.6 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.95 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.04 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.2 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...